ICICI Prudential Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
1,703
-18
-1% -$12.3K 0.12% 128
2026
Q1
$1.33M Buy
1,721
+64
+4% +$49K 0.16% 110
2025
Q4
$1.28M Buy
1,657
+58
+4% +$39.4K 0.15% 110
2025
Q3
$899K Buy
1,599
+269
+20% +$152K 0.09% 122
2025
Q2
$698K Sell
1,330
-48
-3% -$26.8K 0.09% 119
2025
Q1
$874K Sell
1,378
-29
-2% -$19.9K 0.11% 108
2024
Q4
$1M Sell
1,407
-8
-0.6% -$6.71K 0.11% 108
2024
Q3
$1.49M Buy
1,415
+225
+19% +$250K 0.16% 93
2024
Q2
$1.25M Buy
1,190
+116
+11% +$112K 0.15% 94
2024
Q1
$1.03M Buy
1,074
+35
+3% +$33.3K 0.12% 99
2023
Q4
$913K Buy
1,039
+90
+9% +$74.1K 0.11% 96
2023
Q3
$781K Buy
949
+216
+29% +$170K 0.1% 93
2023
Q2
$527K Buy
733
+45
+7% +$34.7K 0.07% 100
2023
Q1
$565K Buy
688
+151
+28% +$114K 0.08% 91
2022
Q4
$387K Buy
537
+144
+37% +$106K 0.06% 88
2022
Q3
$271K Buy
393
+71
+22% +$44.7K 0.04% 93
2022
Q2
$192K Buy
322
+16
+5% +$10.4K 0.04% 96
2022
Q1
$212K Buy
306
+46
+18% +$29.1K 0.03% 94
2021
Q4
$164K Buy
+260
New +$160K 0.02% 90

Other funds holding REGN

ICICI Prudential Asset Management's REGN Position: Q2 2026 in Review

ICICI Prudential Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1% in Q2 2026, selling an estimated $12.3K and leaving 1,703 shares worth $1.06M. The position accounts for 0.12% of the portfolio, ranked #128.

ICICI Prudential Asset Management first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.49M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • ICICI Prudential Asset Management held 1,703 shares of Regeneron Pharmaceuticals worth $1.06M as of Q2 2026.
  • ICICI Prudential Asset Management sold 18 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.3K.
  • Regeneron Pharmaceuticals made up 0.12% of ICICI Prudential Asset Management's portfolio in Q2 2026, its #128 holding.
  • ICICI Prudential Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • ICICI Prudential Asset Management's Regeneron Pharmaceuticals position peaked at $1.49M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on ICICI Prudential Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.